FDA Outlines Clinical Pharmacology Considerations in Pediatric Trials

Clinical Trials Advisor
A A
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00